Effect of Concentration and Ka on Titration Feasibility

Feasibility screening based on $CK_a$ (or the analogous $CK_b$, $CK_f$, and $\Delta E^\circ$ criteria for other titration types) is not a historical curiosity — it is a routine gatekeeping calculation in modern method development. Pharmaceutical quality control labs validating an acid–base assay for a drug substance must check, before ever running a titration, whether the compound's functional groups (often weak acids or bases with $\mathrm pK_a$ values between 3 and 10, and concentrations dictated by dosage-form solubility limits) will give a usable endpoint; many active pharmaceutical ingredients are instead assayed by non-aqueous titration in glacial acetic acid or another differentiating solvent precisely because their aqueous $K_a$ is too small to satisfy the feasibility threshold — a direct, industrial-scale application of the logic developed here. Environmental and water-quality laboratories run into the same constraint when titrating very dilute natural-water samples for alkalinity or acidity: at concentrations near $10^{-4}$–$10^{-3}$ M (typical for weakly buffered surface waters), only relatively strong-acting species (carbonic acid's first dissociation, or strong mineral acidity) give usable potentiometric breaks, while weaker contributing equilibria are folded into a smooth, gently sloping curve and estimated by Gran-function linearization rather than by looking for a visual inflection. In biochemistry and clinical chemistry, the same $CK_a$ logic underlies why physiological buffers (bicarbonate, phosphate, protein histidine residues, each with $\mathrm pK_a$ near physiological pH and millimolar concentrations) are excellent buffers but would make terrible titration analytes — their whole biological utility (resisting pH change, i.e., a flat titration curve near their $\mathrm pK_a$) is the mirror image of what a titrimetric method needs (a sharp curve at the endpoint). Understanding feasibility in the titration sense thus directly illuminates why buffering capacity and titratability are opposite requirements on the same underlying equilibrium chemistry — a conceptual bridge worth carrying into the study of Polyprotic Acid Titration Curves, where the feasibility criterion must be applied separately, and self-consistently, to each successive dissociation step.

Ask the tutor: For a diprotic acid with $K_{a1}=1.0\times10^{-3}$ and $K_{a2}=1.0\times10^{-8}$ at 0.10 M, is the second equivalence point separately feasible, and how would I check it?

Picture the titration curve of a weak acid HA with strong base as three physically distinct regions glued together: a rising buffer region (before equivalence), a steep transition (at equivalence), and a leveling excess-base region (after equivalence). The buffer region is controlled by the Henderson–Hasselbalch relationship and is inherently gentle — that is what a buffer is for. The steepness the analyst actually needs comes entirely from the transition region, where the solution stops being a good buffer because one of the buffer components (HA) has essentially run out. The key physical fact is this: right at equivalence, the solution is not neutral — it is a solution of the conjugate base A⁻ in water, and its pH is set by the hydrolysis equilibrium $\text{A}^- + \text{H}_2\text{O} \rightleftharpoons \text{HA} + \text{OH}^-$. How far this hydrolysis proceeds — and therefore how far the equivalence-point pH sits from neutral — depends on $K_b = K_w/K_a$ and on the concentration of A⁻ at that point, $C_{eq}$. A weaker acid (smaller $K_a$, so its conjugate base is a stronger base) produces more extensive hydrolysis and a farther-from-7 equivalence pH. Dilution lowers $C_{eq}$, which also pushes the equivalence pH toward neutral because a more dilute base hydrolyzes proportionally more (fractional dissociation increases as concentration drops), but the absolute change is modest — a factor of 10 dilution shifts $\mathrm{pH}_{eq}$ by only $\log\sqrt{10}\approx 0.5$. The steepness of the break, however, is far more sensitive to both $C$ and $K_a$ than the equivalence pH itself, because steepness depends on how quickly the solution's buffering capacity collapses as the last bit of HA is consumed. A dilute or very weak acid never builds up much buffering capacity in the first place (small $[\mathrm{HA}]_0$, or $K_a$ so small that little dissociates), so there is little capacity to lose — the curve near equivalence is already nearly flat well before you get there, because the solution was poorly buffered even at 50% titration. This is the mechanistic reason the $CK_a$ product, not either factor alone, governs feasibility.

Now contrast concentration effects with $K_a$ effects at fixed concentration. Weakening the acid (lowering $K_a$ while holding $C = 0.10$ M) has a qualitatively similar effect: the buffer region shifts to higher pH (since $\mathrm{pH}\approx \mathrm{p}K_a$ at half-equivalence), and the jump shrinks, because a weak conjugate acid means a strongly hydrolyzing conjugate base whose own buffering (from the large excess of un-reacted A⁻/HA left over at 99.9% completion) extends further and further past the "true" equivalence point.

The equivalence-point pH for titrating a weak acid HA (initial concentration $C_0$, volume $V_0$) with strong base of matching or arbitrary concentration, at the point where moles base added equal moles HA initially present, follows from treating the resulting solution as a simple solution of the conjugate base A⁻ at concentration $C_{eq}$:

where: — $\mathrm{p}K_a = -\log K_a$ for the weak acid, — $C_{eq}$ is the analytical concentration of A⁻ at the equivalence point (moles of original HA divided by the total volume, HA solution plus titrant added), — the "7" arises from $K_w = 10^{-14}$ at 25 °C ($\mathrm{pOH}=\tfrac12\mathrm{p}K_b - \tfrac12\log C_{eq}$, then $\mathrm{pH}=14-\mathrm{pOH}$).

Reading: every factor-of-10 decrease in $K_a$ (weaker acid) raises $\mathrm{pH}_{eq}$ by 0.5 unit; every factor-of-10 dilution at equivalence lowers $\mathrm{pH}_{eq}$ by 0.5 unit. The two effects are symmetric in this formula but act oppositely on where $\mathrm{pH}_{eq}$ sits relative to 7 — dilution always pulls it back toward neutral (feasibility-hurting direction being pH closer to a flat region), while decreasing $K_a$ pushes it further from 7 while simultaneously flattening the curve. The paradox — moving pH further from 7 while the curve gets less steep — is resolved by looking at the jump, not the equivalence pH, which is the second core relationship. A working measure of feasibility is the size of the pH change across the interval from 99.9% to 100.1% titrated (a standard "sharpness window" corresponding to the $\pm 0.1\%$ volumetric precision of a well-calibrated buret). Just before equivalence (say, fraction titrated $f = 1-\varepsilon$ with $\varepsilon$ small), essentially all HA is converted except a tiny leftover; just after ($f=1+\varepsilon$), there is a tiny excess of strong base. Approximating both sides:

where: — the leading behavior of the jump size scales with $\log(CK_a)$ once the excess-strong-base contribution (which is independent of $K_a$ and controlled purely by dilution) is added in, — "const." bundles the fixed contributions from $K_w$ and the chosen $\varepsilon$ window, — this is not an exact closed form (the full expression requires solving a cubic in $[\mathrm H^+]$ near equivalence) but it captures why the practically used feasibility threshold is stated as a bound on the product $CK_a$, not on $C$ or $K_a$ individually.

Reading: the jump does not depend on $C$ and $K_a$ through some complicated combination — to leading order it depends on their product. This is why the standard teaching rule is stated as $CK_a\gtrsim10^{-8}$: it is precisely the statement that $\log(CK_a)\gtrsim-8$, i.e., that the leading term in the jump-size expression stays above the noise floor set by how precisely pH or an indicator color can be read (typically $\pm0.1$–$0.3$ pH unit of genuine ambiguity in color-change titrations).

Example 1 — Foundational: is 0.120 M chloroacetic acid titratable, and where does its equivalence point sit? Chloroacetic acid, $K_a = 1.36\times10^{-3}$ ($\mathrm pK_a=2.867$), is titrated as a 0.120 M solution ($V_0=25.00$ mL) with 0.150 M NaOH. Feasibility check first.

This exceeds $10^{-8}$ by four orders of magnitude — an unambiguous, comfortably titratable system, expected to give a break of several pH units. Equivalence volume. Moles HA $= 0.120\ \mathrm{mol/L}\times0.02500\ \mathrm L = 3.00\times10^{-3}$ mol. Then

Concentration of A⁻ at equivalence. Total volume $= 25.00+20.00=45.00$ mL, so

Equivalence-point pH, using the derived relation:

So the equivalence point sits at pH 7.85 — mildly basic, as expected for the conjugate base of a moderately strong weak acid, and well inside the transition range of phenolphthalein (8.0–9.6, admittedly at the low edge — bromothymol blue, 6.0–7.6, or a calculated potentiometric endpoint would be safer choices, foreshadowing the indicator-selection logic developed under Acid-Base Indicators: Theory and Transition Range). The comfortably large $CK_a$ value guarantees a sharp break; the choice of indicator is then a secondary, separate question of matching the transition range to $\mathrm{pH}_{eq}$.

Example 2 — Applied: standardizing a NaOH solution against potassium hydrogen phthalate (KHP), and checking whether dilution during the titration compromises the endpoint. KHP (monoprotic as the acidic proton relevant here, $K_a = 3.9\times10^{-6}$, $\mathrm pK_a = 5.41$) is a National Institute of Standards and Technology-traceable primary standard. Suppose 0.7112 g of KHP (molar mass 204.22 g/mol) is dissolved in 75.00 mL of water and titrated with NaOH of nominal concentration 0.1000 M. Moles KHP:

Predicted equivalence volume:

Initial concentration of the acidic proton:

Feasibility:

Still comfortably above the $10^{-8}$ threshold (by a factor of 18), so KHP remains a workable, if noticeably gentler, titration than chloroacetic acid — consistent with the well-known practical fact that KHP titrations require a carefully chosen indicator (phenolphthalein, transition 8.0–9.6) and careful technique near the endpoint, rather than being "sloppy-proof" the way a strong-acid/strong-base titration is. Equivalence pH, with $C_{eq}$ computed at total volume $75.00+34.83=109.83$ mL:

This lands squarely in phenolphthalein's transition range (colorless below ~8.0, fully pink above ~9.6, with the visually detected color change typically perceived around pH 8.5–9), explaining the traditional pairing of KHP standardizations with phenolphthalein and the classic advice to titrate to "the first persistent faint pink," since the true equivalence pH (8.96) sits above the midpoint of the indicator's range — titrating to full, robust pink would systematically overshoot $V_{eq}$. Sensitivity check — does the exact concentration of KHP matter much? Suppose a student mistakenly dissolves the KHP in only 25.00 mL instead of 75.00 mL (a 3× concentration error in the analyte, though the titrant strength is unaffected). Then $C_0' = 3.483\times10^{-3}/0.02500=0.1393$ M, and $CK_a$ rises to $5.4\times10^{-7}$ — the titration becomes sharper, not worse, and $V_{eq}$ is unchanged (it depends only on moles of KHP and molarity of titrant, not on the volume of water used to dissolve the solid). This confirms an important practical point: diluting the analyte before titrating affects curve sharpness and equivalence pH, but never the stoichiometric endpoint volume itself — a fact worth isolating explicitly since it is easy to conflate "dilution hurts the curve" with "dilution biases the result," which it does not.

Example 3 — Exam/competition level: two structurally similar weak acids, only one of which is titratable, and finding the minimum concentration at which the second becomes marginally feasible. Acid A: $\mathrm pK_a = 4.20$ ($K_a=6.31\times10^{-5}$). Acid B: $\mathrm pK_a = 8.90$ ($K_a=1.26\times10^{-9}$), structurally similar (say, a substituted phenol) but far weaker. Both are prepared at $C=0.0500$ M. Acid A feasibility:

Well above $10^{-8}$ — clearly titratable, with equivalence pH (at, say, $C_{eq}\approx0.025$ M after dilution by titrant) of

a clean break usable with phenolphthalein or a pH meter. Acid B feasibility:

This is roughly three orders of magnitude below the $10^{-8}$ threshold — acid B is not titratable at this concentration by any ordinary means. Its titration curve would be nearly indistinguishable from adding strong base to pure water: the "buffer region" barely exists because so little of the acid dissociates even at the start, and the equivalence-point break is buried in a curve that is already almost flat throughout. Question: at what concentration would acid B become marginally titratable ($CK_a = 10^{-8}$, the threshold itself)?

This is a striking and instructive result: 7.9 M is far beyond the solubility of essentially any real weak acid in water (and would in any case violate the dilute-solution assumptions built into the derivation, such as ignoring activity coefficients and ionic strength effects). The calculation demonstrates concretely that acid B, with $\mathrm pK_a=8.90$, cannot be made titratable in aqueous solution by any practically achievable concentration increase — the only fixes are a nonaqueous solvent (which changes the effective $K_a$ entirely) or an entirely different analytical method, such as back-titration or a spectrophotometric approach, rather than direct acid–base titration in water. Limiting-case sanity check on Example 3: setting $\mathrm pK_a$ for acid B down to 6.90 instead of 8.90 (i.e., $K_a=1.26\times10^{-7}$, a hundredfold stronger acid) gives $C_{min}=10^{-8}/1.26\times10^{-7}=0.079$ M — a perfectly ordinary, easily prepared concentration, showing the threshold behaves continuously and sensibly as $K_a$ is dialed between "impossible" and "routine."

The systematic, quantitative treatment of titration feasibility — going beyond qualitative "is it possible" toward a numerical criterion based on the size of the achievable break — is most closely associated with the Finnish analytical chemist Anders Ringbom, whose mid-twentieth-century work on complexometric and acid–base titration theory formalized the idea that a titration's usefulness could be quantified by the magnitude of the discontinuity in a titration function at the stoichiometric point, expressed as a function of the relevant equilibrium constant and concentration. Ringbom's approach — computing the change in a "p-function" (pH, pM, or pE depending on titration type) across a narrow window around the equivalence point, and comparing it to the resolving power of the detection method — is the direct ancestor of the $CK_a$-type feasibility criteria used in every modern analytical chemistry course, and it generalizes cleanly to complexometric titrations (feasibility governed by $CK_f$, the conditional formation constant) and redox titrations (feasibility governed by the separation of standard potentials, foreshadowing later material on redox titration curves).